Grants - AWARD SUMMARY


GLSYNTHESIS INC.


Oligomeric, conjugated water soluble (p-phenylene-ethynes) (“OPEs”) are strongly fluorescent at long wavelengths and are "superquenchable" by interaction with appropriate small molecules. They and the polymeric versions (“PPEs”), however, have significant drawbacks as biomolecular probes in aqueous solution. They are long rodlike (bulky) structures and display considerable temperature- and salt concentration-dependence in their fluorescence properties as a result of aggregation in aqueous solutions. We have prepared a minimal length oligomer of this type, a “3.5-mer” [based on three repeating phenylene-ethyne units capped with a phenyl group, i.e. “0.5 unit”], that has significant fluorescence yield and does not show the temperature and salt-dependence of its fluorescence in water. The latter property makes this and related “OPE3.5” oligomers potentially useful as probes for study of biomolecular interactions. We will use an efficient, solid state synthesis approach to prepare a limited family of specific, highly fluorescent oligomers - oligo(p-phenylene-ethyne)s (“OPEs”). The compounds will possess a free carboxyl group at one terminus, enabling them to be covalently attached to biomolecules such as proteins and nucleic acids. In order to assess their potential utility, one oligomer will be conjugated to the drug-binding protein human serum albumin (HSA), and the interaction of the construct with typical drugs will be measured by observing changes in fluorescence, i.e. quenching, as a function of concentration. The specific aims of this project are to: 1. conduct solid state synthesis of four substituted “OPE3.5-mers” containing terminal carboxy groups; 2.characterize the fluorescence properties (excitation and emission spectra, quantum yield, potential for aggregation) of the synthesized compounds; 3. activate and covalently attach a selected oligomer to human serum albumin (HSA), and characterize the stoichiometries and fluorescence properties of the products, and 4. study the effect of interaction with typical albumin-binding drugs on the fluorescence of the HSA-oligomer conjugates. The synthesis and properties of related hydrophobic and hydrophilic, i.e. water soluble, polymers have been reported, but no systematic studies of related oligomers have been reported. Thus, their potential as biomolecular probes is unexplored. The novel oligomers and their reactive derivatives will represent breakthroughs in assay development, and will be offered for sale to companies and research institutions for discovery of new applications of these materials.

Clarification of Codes

Choose a quarter and click "Go."


AWARD OVERVIEW

AWARD OVERVIEW
Award Number 1R43GM093694-01 Funding Agency Department of Health and Human Services
Total Award Amount $191,458 Project Location - City Worcester
Award Date 06/14/2010 Project Location - State MA
Project Status Completed Project Location - Zip 01605-4307
Jobs Reported 3.00 Congressional District 03
Project Location - Country US

Recipient Information (Grants)

Recipient Information (Grants)
Recipient Name GLSYNTHESIS INC.
Recipient DUNS Number 003231854
Recipient Address 1 INNOVATION DR STE 4
Recipient City WORCESTER
Recipient State Massachusetts
Recipient Zip 01605-4306
Recipient Congressional District 03
Recipient Country USA
Required to Report Top 5
Highly Compensated Officials
No

Projects and Jobs Information

Projects and Jobs Information
Project Title Solid state synthesis and applications of oligo(phenylene-ethynes)
Project Status Completed
Final Project Report Submitted Yes
Project Activities Description Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Quarterly Activities/Project Description 1. Preparation of “carboxy-terminated, anionic 3.5-mer phenylene-yne”, lot XU-V-60. Using the intermediate prepared in the last quarter we succeeded in preparing this key phenylene-yne oligomer consisting of sulfonyloxypropyl groups at the 2 and 6 positions of phenylene groups and terminal carboxy groups. The product was obtained by separation on a C18 preparative column, and elution with a shallow gradient of 7% acetylnitrile to 20% over 60 min. The first large peak at 45 min was the desired product by LCMS,6.2 mg, lot XU-V-60. This material was dissolved in water to give a 1 mM stock solution. 2. Fluorescence of anionic 3.5-mer. The product had excitation at 400 nm and emission at 450 nm, with several million counts at 5 µM in water. The Stern-Volmer plot gave a S-V constant of 4000 (r2 = 0.9962). For subsequent experiments an excitation wavelength of 425 was used to avoid the excessive brightness and because many drugs have excitation peaks close to 400 nm. 3. Fluorescence properties of anionic 3.5-mer. Three tests, stirring, salt effect and temperature effect, were used to evaluate the fluorescence stability and, thus, potential utility of this 3.5-mer. All tests were negative. 4. The analogous “neutral” 3.5-mer containing methoxy groups at the 2 and 6 positions and terminal carboxy groups has been prepared, and is being isolated. Its fluorescence properties will be measured as in 3 above, and it will also be attached to BSA. 5. Conclusions. The anionic 3.5-mer, lot XU-V-60, is very bright and stable. It passed all the fluorescence stability tests. The final step, not yet accomplished, is to attached it covalently to BSA and evaluate it as a drug binding probe.
Jobs Created 3.00
Description of Jobs Created 00


Purchaser Information (Grants)

Purchaser Information
Contracting Office ID Not Reported
Contracting Office Name Not Available
Contracting Office Region Not Available
TAS Major Program 75-0852

Award Information

Award Information
Award Date 06/14/2010
Award Number 1R43GM093694-01
Order Number
Award Type Grants
Funding Agency ID 75
Funding Agency Name Department of Health and Human Services
Funding Office Name Not Available
Awarding Agency ID 75
Awarding Agency Name Department of Health and Human Services
Amount of Award $191,458
Funds Invoiced/Received $191,458
Expenditure Amount $191,458
Infrastructure Expenditure Amount $191,458
Infrastructure Purpose and Rationale Not Reported
Infrastructure Point of Contact Name Not Reported
Infrastructure Point of Contact Email Not Reported
Infrastructure Point of Contact Phone Not Reported
Infrastructure Point of Contact Address Not Reported
Infrastructure Point of Contact City Not Reported
Infrastructure Point of Contact State Not Reported
Infrastructure Point of Contact Zip Not Reported

Product or Service Information (Grants)

Product or Service Information
Primary Activity Code 541712
Activity Description Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Sub-Awards Information

Sub-Awards Information
Sub-awards to Organizations 0
Sub-award Amounts to Organizations $0
Sub-Awards to Individuals 0
Sub-Award Amounts to Individuals $0
Number of Sub-awards less than $25,000/award 0
Amount of Sub-awards less than $25,000/award $0
Number of payments to vendors greater than $25,000 0
Total Amount of payments to vendors greater than $25,000/award $0
Number of payments to vendors less than $25,000/award 0
Total Amount of payments to vendors less than $25,000/award $0







Project Location Detail

Location Information
Latitude, Longitude 42º 16' 34", -71º 46' 2"
Congressional District 03
Address 1 One Innovation Drive
Address 2
City Worcester
County Worcester
State MA
Zip 01605-4307
Submit Feedback/Comments: Provide feedback or comments on the performance and progress of awards.